posted
HOT STOCK ALERT ACCUMULATE NOW GSI SECURITIZATION LTD. (GSIEF)
Recent Price: .007 Average Volume: 450,000 Previous Annual High: .10 Long Term Target Price: $2.00 Industry: Healthcare; Non cyclical; 23% of GNP; no downturn in growth
Recommendation: SHOULD BE NEAR $0.25-$0.50 SOON
Spotlight: New business long-term contracts in final stages that are highly profitable. Compounded growth is enormous capitalizing on this $12-billion healthcare market representing 23% of the GNP and growing. Expanded business relationship growth is generating new explosion in targeted sales through diversified products portfolio services. Venture partners and the strength of the industry for the sale of GSI’s financial and support products holds long-term fundamental strength and capital appreciation to its shareholders.
Posts: 1 | Registered: Jun 2007
| IP: Logged |
A Large Southwest Hospital Has Initialed the First Stage of Its Receivable Agreement Tuesday June 26, 10:16 am ET
PRINCETON, N.J., June 26 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk - News) is pleased to announce today that their subsidiary GSI Securitization Inc. has been notified that it will receive an accounts receivable portfolio for their review and analysis. These receivables are from a very large hospital system representing several millions of dollars. The cost to profit ratios should permit significant growth potential to the company and its shareholders. ADVERTISEMENT
Gunther Slaton, CEO of GSI stated, "This secular market continues to show growth since it is in its early stages, any significant downturn will be several years away. Compounding the growth is the need for providing continued medical services, keeping up with technology, equipment and plant needs. GSI marketing group supplies the capital sources and servicing (oversight control) to assure that the capital investors products are sold based solely upon provider assets to funding ratios, payback timing and this system provides for an improved profit picture."
Statements released by GSI Securitization Inc. that are not purely historical are forward looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. The company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental and technological factors as discussed in the company's filings with the SEC on Forms 10-K, 10-Q and 8-K. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
-------------------------------------------------------------------------------- Source: GSI Securitization Inc.
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
GSI Initial Phase Agreement for a Specialty Physician Group to Recapitalize Their Business Wednesday June 27, 11:13 am ET
PRINCETON, N.J., June 27 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk - News) announces today that their subsidiary GSI Securitization Inc. will receive an accounts receivable portfolio from a specialty physician group wanting to capitalize their receivables at discount rates to access cash flow for expansion and other business enterprise venues. ADVERTISEMENT
Gunther Slaton, CEO of GSI stated, "This is another opportunity for accruing growth for investors capitalizing GSI's exclusive business management expertise in dealing with this specialized healthcare industry of diversified portfolios of medical care services with the combination of financing sources, account servicing, expansions, mergers & acquisitions and other finance products."
In the past several weeks, we have announced five agreements in our industry as well as the size and scope of the field. The company expects to have the results in the coming weeks from the due diligence process. Our funding source partners will be finishing the work of evaluation of the receivables and the bidding process; we will be able to report the progress to the marketplace for our projects.
Statements released by GSI Securitization Inc. that are not purely historical are forward looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. The company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental and technological factors as discussed in the company's filings with the SEC on Forms 10-K, 10-Q and 8-K. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
-------------------------------------------------------------------------------- Source: GSI Securitization Inc.
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
GSI Sees Long-Term Growth Opportunity in $2 Trillion Healthcare Market Growing at 8.6% Yearly Monday July 2, 4:43 pm ET
PRINCETON, N.J., July 2 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk - News) sees the coming long term growth opportunity positioning to provide investors more growth, profit and security of investment as it captures a larger share of the $2 trillion+ healthcare market expenditures, growing at 8.6% yearly because of the different platforms offered. ADVERTISEMENT
GSI brings to investors insight into GSI's business for offering long-term growth of investment in asset-backed financial transactions to the healthcare industry.
GSI is at the heart of this growth supplying 'asset-backed' financing platforms as ... (1) outright purchase of ratable (Fitch and Standard & Poor's) third party insurance receivables; (2) debt financing; and (3) equity/debt financing ... tied to the level of borrowers' cash flow generation and assets. Participation levels are $1-million and up to small, medium, large, for-profit, not-for-profit, public, private healthcare providers.
-- Driver. Providers are at a cross roads, forced by market and regulatory pressures to continually re-evaluate and make changes in ... (i) how they deliver care; (ii) in what setting; (iii) at what cost in order to just maintain the status quo. This is done by changing technology, administration, and/or delivery of patient care services ... all creating demand for capital and back office revenue management support services.
-- Continuous growth. Healthcare providers on average spend 8% on capital improvements. In the last 10 years the nationwide average age of physical plants has increased to 20 percent, add to that equipment needs to stay competitive and you've got the perfect storm of capital expenditure coming, according to Hospitals and Health Networks (H&HN).
-- GSI's uniqueness is in the details. We know the market as top management players in this industry for the last 30+ years on the team. We have developed a proprietary analysis capability to isolate the net value determination of this class of receivable and discounting, resolving or rejecting troubled receivable collections by provider errors and omissions.
-- The GSI business model has a backlog to be funded and several other 'asset-backed' projects under development. Each transaction is prepared to rating agency and investor lending standards.
-- Meeting investor expectation. The investor rewards include ... (1) Safety of investment, (2) long-term or short-term growth, (3) profitability, (4) complete in-depth oversight controls, (5) minimal risk, and (5) lockbox flow of funds managed to Contract Terms.
-- Experience and servicing history. GSI is at the heart of an industry short on cash flow and long mandatory revenue to keep competitive and meet the healthcare demands in today's and tomorrow's growing infrastructure medical care environment. Capturing a position of growth is GSI's relationship with a growing number of synergistic healthcare alliances.
The business model includes years of research and development to meet rating agency, investor and market demands in synchronization across all- sectors of the medical care continuum, supported by extensive reimbursement, a clinical, operational, accounting, contracting and legal professional expertise ... which underscores our emerging market leadership position. Ultimately, sales generation is a networking process because the common theme among medical providers is their desire to partner with a lender that has specific knowledge of their business and capability in providing creative financing solutions.
-- Gunther Slaton. Chairman; CEO and Founder of GSI Securitization Ltd. is considered an expert in the healthcare finance business in the development of business opportunities for asset-backed high profit, low risk business. He started by working with physician groups in the purchase of hospitals and moved into asset-backed financing instruments setting up a business model experienced in profiling client needs, analysis of data to budgeting and oversight controls of investments to this medical services market covering hospitals, physician groups, specialty hospitals, etal.
He works with all layers of management (1) the financial community meeting prerequisite funding; (2) processing and collection dynamics to secure optimum reimbursement for funds employed in purchasing accounts receivable; (3) security of funds protocol; (4) 24/7 reporting; and (5) operations standards.
His background as an engineer, business financial expertise, know of the healthcare industry, and its shortfalls, which have become opportunities for GSI's emerging growth has propelled GSI's business model into a public company affiliating marketing, sales, operations and reporting aspects of the business. This is management on a collaborative scale for optimum business development, cost effectiveness, and profit for the stockholders.
Beyond healthcare, Mr. Slaton was the general manager of the JELLO Division of General Foods, prior to the purchase by Kraft Foods. In other venues, he worked in the healthcare industry in different capacities in pharmaceuticals and OTC products for consumer consumption. He built, owned and operated a manufacturing and development company in partnership with USM. He graduated from New York's prestigious Stuyvesant in two years; went to the University of Wisconsin on scholarship and received a B.S. Degree in engineering; and then went to Harvard Business School. He received the Gilbreth Award Metal for high achievement in management. Mr. Slaton was born in Germany.
-- Sally Engel. Vice President Marketing and Sales of GSI Securitization Ltd. is key to business develop, processing and details of management of the business working with all phases of the financial product(s) sales, from inception to contract, and then is involved in reporting and management of oversight of the processes. A complex job covering client relationships, focused sales on individual client needs, proposals, finalizing business deal for contracting done in coordination with Mr. Slaton and all parties involved in the sale, financing and servicing of any business coming into GSI.
In addition, she is responsible for advertising and promotions of GSI and has worked extensively with research, development, demographic, market analysis, design and implementation of graphic and presentations to various targeted markets. In that environment, she is responsible for all individual sales packages with prospective client presentation and specific market product and business offerings. She also works with the public sector with GSI in public relations and stockholder relations.
She has designed, implemented and sold multiple products and services to the healthcare industry and consumer markets expanding profitable market share for Fortune 500 companies, such as FORT DODGE LABORATORIES, AMERICAN HOME PRODUCTS, CARNATION ALBERS, and BLISTEX, etal. She has been involved with GSI from its inception. She attended the University of Kansas majoring in Marketing and Business, Northwestern University business development courses in the Psychology of Marketing through Advertising, Entrepreneurship in Business, and New Trier extension courses in computer technology.
Statements released by GSI Securitization, Inc. that are not purely historical are forward looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. The company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental and technological factors as discussed in the company's filings with the SEC on Forms 10-K, 10-Q and 8-K. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
GSI Elects Stockholder Dr. Steven J. Phillips to Board Monday July 2, 4:46 pm ET - Dr Phillips, a national leader in healthcare and an acclaimed General and Thoracic Surgeon, will be a principal advisor to the chairman - Dr. Phillips brings a wealth of experience as a former White House nominee, a successful business entrepreneur, inventor, a revenue cycle management expert and an appointee to the Board of Regents of National Library of Medicine
PRINCETON, N.J., July 2 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk - News) has elected stockholder Dr. Steven J. Phillips to its board. ADVERTISEMENT
His illustrious background:
Steven J. Phillips, M.D. -- Principal Advisor to the Chairman -- Dr. Phillips brings an important dimension to our organization because of his in depth understanding of the transitions emerging in healthcare reimbursement and finance. He has enjoyed a highly successful career as a board certified General and Thoracic Surgery, and well as being a successful business entrepreneur. He established a cardiac surgery program at the University of Oregon to Des Moines, Iowa which today the Iowa Heart Center, a private medical group that has grown to more than 55 physicians and 300 employees, all specializing in cardiovascular disease and a highly profitable business. Dr. Phillips team pioneered techniques for emergency coronary bypass surgery for evolving heart attacks. His concept of acute intervention during a heart attack is presently the universal standard of care. He developed a funded Cardiovascular Research Laboratory at the College of Veterinary Medicine, Iowa State University. During the past 30 years his team implanted the first artificial heart in Iowa, performed the first heart transplant in central Iowa, and invented the technology for percutaneous cardiopulmonary bypass. He has been the principal investigator for numerous research projects. He retired from active medical practice in 2005. In 1997 Dr. Phillips was interviewed by the White House Search Committee for the position of Commissioner of the Food and Drug Administration. On October 7, 1998, he was invited to testify before the Full Committee on Commerce as a witness on the Implementation of the Food and Drug Administration Modernization Act of 1997. He was appointed a member of the Board of Regents of the National Library of Medicine (NLM) of the National Institutes of Health (NIH) and served from 1993-97. He was the 1997 Board Chair. In 1999 he was appointed as the full time Deputy to the Director for Research and Education at the NLM, NIH. In 2002 Dr. Phillips became a founder of and the Chief Medical Officer of Cardiovascular Hospitals of America, LLC. He retired from that position in 2001 but remains an NIH contractor.
Dr. Phillips served twice in Vietnam. He served with the 101st Airborne Division in Vietnam. Stateside he was assigned to the Department of Experimental Surgery at the Walter Reed Army Institute of Research. He returned to Vietnam with a research team to study the effects of altitude on the wounded being flown from Vietnam to the Philippines and Japan .He remained a reserve officer until his retirement as a Lieutenant Colonel. He is a life member of the 101st Airborne Association and an invited Associate Life Member of the UDT/SEAL Association. He has received numerous awards for science and community and charitable service including the International Variety Club Life Time Achievement Award. Dr. Phillips received the Governor of Iowa Science Medal for his scientific efforts and he was the National Science Advisor to the Iowa Department of Health. He presently serves as the North American Editor of the Journal of Artificial Organs, serves or served on numerous editorial, medical society and corporate boards including Dr. Michael E, DeBakey's company, Micromed, Inc., Cobe Laboratories, Inc., and Medical, Cardiovascular, Inc. Dr. Phillips is past president of the Polk County Medical Society, Iowa, past president of the Society of Cardiac Surgeons, Spain; and past president of the American Society for Artificial Internal Organs, USA. He has an active medical license in Iowa and Colorado, has approximately 300 medical publications, and has been granted 6 patents. He is a graduate of Hobart College and Tufts University School of Medicine.
Statements released by GSI Securitization, Inc. that are not purely historical are forward looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. The company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental and technological factors as discussed in the company's filings with the SEC on Forms 10-K, 10-Q and 8-K. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
Compounding Growth Potential With Funding New Business Developments Capitalizing GSI, Medicredit Joint Venture Proficiencies Friday July 6, 1:27 pm ET
PRINCETON, N.J., July 06 /PRNewswire-FirstCall/-- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk - News) -- The drivers behind this business are enormous as we (MediCredit & GSI) expand the 17 year established, highly profitable and growth business model to broaden the market scope for specialty Insurance Claims purchases due from the Fortune 500 insurance companies. ADVERTISEMENT
It is a stockholders and investors best opportunity to expand the multiples that we forecast with this business relationship. MediCredit is presently discussing with healthcare providers how to access cash flow without waiting or attempting to manage the specialty Insurance Claims that they generate. The diagnostic, clinical and rehabilitation care business will result in hundreds of millions of dollars. Each state with no fault insurance mandates insurance companies must provide for whatever services are prescribed.
The growth comes in direct proportion to funding capital availability and the market in which these funds are employed for high profitability and security of investment. Principal rated insurance companies involved in these unique business payments, include, but are not limited to, Allstate, State Farm, Liberty Mutual, Nationwide, MIC (GMAC), General Assurance, Prudential, Aetna, Geico, Hartford, Progressive, Countrywide, Encompass, Metropolitan Insurance.
Gunther Slaton, President of GSI states, "The long-term wrap-up for expanding GSI's business in this arena is expected to compound profits many time over with the expansion of MediCredit's niche market business potential. The President and CEO of MediCredit, Seymour Spilka brings to the table a winning combination for investors capitalizing the relationship building processes with the healthcare community that takes years to develop and to obtain a following for the type business MediCredit and Seymour have created over the past 17+ years."
It is no secret that in this industry, unlike other industries, it is not a widget sale, but rather a long term, continual credentialing type relationship that builds momentum with time. Healthcare providers want to deal with people they know and it becomes network selling. No sale is done overnight and usually, once connected you are connected long term and then get referrals as each Client is treated with special handling. We are cognizant of the patients, the physicians, the treatments, and the reimbursement protocols all of which are key elements in the services and funding instruments sold in this $2-trillion+ market."
Gunther Slaton, President of GSI states, "Seymour Spilka represents the paradigm for specialty insurance funding and servicing aspects of this receivable business. His resume states it all for the investors."
Seymour Spilka, President and CEO, started MediCredit, Inc. in 1990, managing a portfolio of healthcare providers specializing in the no-fault insurance arena financing programs. Mr. Spilka set-up, coordinated, and managed the entire operations of the company in the marketing, sale, net-value determination modeling, financing, processing and collection, accounting and services of the existing and prospective Client base. The asset-backed business has continued to be highly successful and profitable as a niche market specialty business. Mr. Spilka has in excess of 40 years of in-depth experience in the insurance business, financing of receivables insurance no- fault business, processing and collection. President of General Factors Company, started as insurance premium finance company, expanded into commercial financing and leasing. In addition, he was Vice President of Western Plains Mutual Insurance Company handling specialty surplus lines insurance, Penn General Capital Corporation, subsidiary of Pennsylvania Life Insurance Company Vice President, Bankers and Shippers Insurance Company Director, subsidiary of Pennsylvania Life Insurance Company, sold to Travelers Insurance Company.
Statements released by GSI Securitization Inc. that are not purely historical are forward looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. The company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental and technological factors as discussed in the company's filings with the SEC on Forms 10-K, 10-Q and 8-K. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
-------------------------------------------------------------------------------- Source: GSI Securitization Inc.
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
Consultants Seek to Join the Growth and Remuneration Available Through the GSI & MediCredit Joint Venture Business Model Friday July 6, 2:34 pm ET
PRINCETON, N.J., July 6 /PRNewswire-FirstCall/ -- MediCredit has announced to GSI (OTC: GSIEF - News) that it is in the process of securing a Representative Agreement with a healthcare consultant to bring interested medical groups or individuals to GSI for funding healthcare patient accounts receivables from third-party insurance rated payors, expanding the sale, marketing and servicing arm for the joint venture group. ADVERTISEMENT
Gunther Slaton, President of GSI states, "This expansion of the MediCredit business into the New England region is a bonus for the growth of "highly profitable" business for GSI and MediCredit bottom line. We look forward to this opportunity and to future consultants who wish to capture a piece of residual highly profitable business model through sales and servicing the business they bring in."
Statements released by GSI Securitization ,Inc that are not purely historical are forward looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. The company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental and technological factors as discussed in the company's filings with the SEC on Forms 10-K, 10-Q and 8-K. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
Share Structure: Auth. 100M O/S 99,462,627 Restricted 33,002,167
Float: 12 million m/l
verified by transfer agent 07/05/07
Compushare Trust Co. Golden, CO 303-262-0889
No Dilution, no outstanding filings for shares.
Confirmed association with Silar Group, NYC. Silar provides the funding to GSIEF for the medical/hospital receievables.
UPDATE: Thursday July 5, 2007
MUST READ GSIEF
Ok folks, we now have r/m confirmation with CMHS.
Also confirmation on how the CEO is going to treat the shareholders of GSIEF.
stocrates verified today that 12 million restricted shares have been issued.
I called CEO Slaton, yes, the shares are issued for the merger closing, yes, the shares issued to effect the merger are restricted.
This tells us three things:
1. The merger into the CMHS OTCBB shell is going to take place.
2. The owners of the CMHS are confident enough in the business of GSIEF to accept all restricted shares.
3. The CEO of GSIEF is a shareholder dream and a financial mastermind, he pulled off this merger with all restricted stock, worth today about 450,000. In exchange, GSIEF gets the OTCBB fully reporting compliant shell, and the 4.7 million dollar loss carryforward carried on CMHS books. Because CMHS is a "like business" under Internal Revenue Service Code, GSIEF can use the tax loss carryforward to shield the first 4.7 million in profits from GSI.
Translation: GSIEF just bought the shell for the restricted stock, and will save about 1.5 -1.7 million dollars in taxes from their first profits.
No free trading shares added to the already low 12 million float !
In all my years in the pinks and bb, I have never seen such a swing in equity and responsible management getting the very best of a deal for the public.
Now folks, if that doesn't illustrate to you what the Captain of this ship is capable of, and what he does to protect shareholder value, I don't know what would.
Posted by: investwise4858 In reply to: None Date:6/27/2007 3:32:58 PM Post #of 62
Begin Message ALL ALERT Wednesday June 26, 2007
PINK SHEET ISSUE REVERSE MERGER INTO OTCBB FULLY REPORTING SHELL
Independent confirmation from two reliable sources.
Pinksheets: GSIEF .01(+ -) GSI Securitizaion, Inc.
GSIEF is at or near all time low.
Auth 100m o/s 87.4m float 12 m
Transfer agent Compushare Trust, Golden CO, ungagged, verified share numbers this morning.
80%+ of GSIEF shares are held by insiders with no intention of selling. 22 m are restricted.
The companies announced in a press release a few months ago that they were going to r/m with the CMHS shell, but not many paid attention. Most gave the CMHS shell the attention and ignored the business being merged into it that will be the surviving entity.
All the papers have finally been signed and it is a done deal. The delay was caused by some debt negotiation matters that pertained to old shell debts that have now been resolved. CMHS filed their 10K last Friday and became compliant.
GSIEF is a company that purchases medical related accounts receivable from hospitals, medical offices, and such, at a discount, they then bill the appropriate insurance provider such as Blue Cross, Medicare/Medicaid, and other major insurance companies.
This provides the participating client medical facility with better cash flow and reduced internal expenses as GSIEF files the appropriate claims and is reimbursed directly, therefore no risk to GSIEF, for all practical purposes.
This “medical factoring” as I will call it, is a huge growing business, the CEO, a 68 yr old man, has been building this business for years, now that he has the thus far unnoticed impressive sales, he is moving from the dark shadow of the pinks to fully reporting OTCBB.
There are some big names behind this company. Bob Leeds (formerly of Goldman Sachs & Nomura Securities) out of Silar Capital, NYC, and a few folks from the LaSalle Bank group that are backing GSIEF. They are providing all the funds for GSIEF to purchase the accounts receivables .
No one has paid mind to these facts, but they soon will.
Make no mistake, GSIEF is the surviving entity in this transaction with all the sales and assets to be placed in the CMHS shell, with CMHS getting 10% ownership in GSIEF. GSIE will be the surviving symbol.
The press releases that were written by the two companies at the beginning of the negotiations were murky as to their objectives, GSIEF is the much better percentage play here overall. They are bringing all the business operations and assets into CMHS shell, there is some merging of management as well. GSIEF shareholders will own 90% after everything is said and done.
Here is a quick synopsis:
Market cap * close Tues:
CMHS shell 17.7m o/s x .06 = $1,005,000 (Ends up with 10% of new company when transaction is complete)
GSIEF 87.4 m x .01 = $ 874,000 (Ends up with 90% of new company when transaction is complete)
No dilution, GSIEF has no IR and refuses all dilutive financing offers.
GSIEF way undervalued, should be trading at .10-.15 or above just on the pinks, if folks understood the business and current revs/profits, higher on OTCBB .
GSIEF (GSIE)will be trading on the OTCBB within 2 weeks.
After placement on OTCBB, the company will announce sales of 30 m and profit of 3-4 m for 2007, they are right in line so far with these numbers thru present day.
Announcement of merger by PR, and later PR of sales to date and 2007 estimates are imminent.
Good luck and health to all.
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
Silar is very impressive group, Bob Leeds, formerly of Goldman Sachs is the CEO.
Then you have Gary Fragin, former Oppenhiemer & Co General Partner.
Heavy hitters here folks, Leeds and Fragin do not get involved with unprofitable and low return ventures...
This is looking real good here folks, there must be some large numbers to be released in sofar as sales and profits for GSIEF...
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
posted
Very informative session on Platalk this evening about GSI! Will look forward to the next session as more devlopments happen...GLTA!
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
Posted by: martingale In reply to: pennypusher1 who wrote msg# 624 Date:7/9/2007 7:32:27 PM Post #of 737
OK-this is what I found: They have 2 offices, the one in which Sally Engle works is located in the Chicago, Ill. area: Tel. 847-679-2290 and Gunther Slaton works out of the Princeton, NJ office.
Sally was saying that rising medical costs have caused medicare and private insurance companies to slow down the payment process to health care providers. In many cases it is now taking 90-120 days to receive payments and this has caused alot of interest in the medical community for their services. You know about the 250 bed hospital with a accounts receivable of $250M they are working on and they have another with an MRI Lab worth 17M. The Medicredit joint venture is going to be huge for them as they have accounts receivable in the hundreds of millions of dollars they are going to start financing. She also stated that they are working with medical practices and hospitals that are wanting to finance their expansion plans, rennovations and new construction with their A/R and they are looking at these deals as well.
There is only one other company that they know of in the U.S. which is in competition with them. As you know and Sally said again, their booking cycle on new business is from 3-6 months leadtime and most of that comes from referrals from other clients. That is one reason why the Medicredit deal will be good for them. It brings referrals now.
From Gunther Slaton in New Jersey this: They have 4 other sources for funding besides Silmar Capital who has the right of first refusual on all new business deals. These are banks and hedge funds. One of these is the Stevens company a large private equities firm located in Little Rock, Ark. Between these 5 sources of funds they can handle all the new business which comes their way.
He went on to say if they can capture a fraction of 1% of the market it would be billions in A/R's.
In regards to the R/M as you know, all of the paperwork on their end as been submitted to the other companies attorneys for review. As far as he knew, the only issue was that the other company needed to come up with some cash to finalize the deal and they were working on it. I only got to talk to Gunther for about 15-20 minutes as he was late to a meeting but I found him very professional and quite interested in talking to shareholders. He went over his backround and it sounds like he has alot of experience in handling large dollar sales with Kraft-jello ($400M year). He has an undergraduate engineering degree and attended graduate school at Harvard. Probably why he still lives in Princton, NJ. He specifically said that I could call him with any questions I had in the future and I did have some but we ran out of time...will get back to him this week.
Nice gain in the price today and it looks that my first buy * 6c was just a little high but I am confident this is a growing company which will do well in the future and I intend to keep adding shares as we go along here. GLTA
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
Posted by: martingale In reply to: pennypusher1 who wrote msg# 628 Date:7/9/2007 7:52:46 PM Post #of 737
Also a couple of other things. Sally stressed that Medicredit had been in business for many years and to date they have not lost any money on any A/R account they have financed. She said they were looking for a source of funding and GSI provided it.
She also said that the Stevens company in Little Rock was the one which led them to Fitch as well as Moody to learn how to securitize their loans so banks would accept them. It was a process which took 2 years.
I also found it interesting that they were willing to fund rennovations and new construction from the medical community if they would pledge their A/R as hard asset backed loans.
Posts: 53 | From: Jax, FL | Registered: May 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
